Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07511439
PHASE4

Reversible Effects of Oral Contraceptive Removal on Serotonergic Neurotransmission

Sponsor: Rigshospitalet, Denmark

View on ClinicalTrials.gov

Summary

The goal of this study is to learn about potential reversible effects of combined oral contraceptive (COC) use on the serotonergic brain system. The main question it aims to answer is: \- If COC discontinuation results in an increase in serotonin 4 receptor binding in caudate, putamen, and hippocampus measured with Positron Emission Tomography from baseline to follow-up ≥ week 8 after discontinuation. The secondary question it aims to answer is: \- Over what timeframe the serotonin 4 receptor binding is restored after COC discontinuation to the level previously seen in a group of premenopausal women who had not used hormonal contraception before. Researchers will compare discontinuation with continuation of a 2nd generation COC containing 150 ug levonorgestrel and 30 microgram to see if COC discontinuation results in an increased serotonin 4 receptor level in the brain. \- Participants will: * Be randomized to discontinue or continue their COC use for 1-52 weeks. * Undergo an investigational program including brain scans, biological sampling, and neuropsychological testing at baseline and at follow-up. The study uses a group sequential design with two sequential analyses planned, including an interim analysis after 60% of the brain scans have been acquired, which will be used to decide the timing of the last 40% of the scans - this is performed to best determine when the recovery of the serotonin 4 receptor level occurs.

Key Details

Gender

FEMALE

Age Range

18 Years - 39 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2026-04-01

Completion Date

2030-12-31

Last Updated

2026-04-09

Healthy Volunteers

Yes

Interventions

DRUG

Discontinuation of 2nd generation combined oral contraceptive use

Discontinuation of 2nd generation combined oral contraceptive use

DRUG

Continuation of 2nd generation combined oral contraceptive use

Continuation of 2nd generation combined oral contraceptive use

Locations (1)

Neurobiology Research Unit (NRU)

Copenhagen, Denmark